Medicus Pharma
MDCX
23 hedge funds and large institutions have $1.18M invested in Medicus Pharma in 2026 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 7 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
10% more funds holding
Funds holding: 21 → 23 (+2)
3.17% less ownership
Funds ownership: 7.8% → 4.63% (-3.2%)
82% less capital invested
Capital invested by funds: $6.48M → $1.18M (-$5.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$118K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$86.2K |
| 3 |
SIAP
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
|
+$35.4K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.1K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$10.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$110K |
| 2 |
VF
Virtu Financial
New York
|
-$34K |
| 3 |
ICP
Interchange Capital Partners
Pittsburgh,
Pennsylvania
|
-$26.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$18.6K |
| 5 |
BlackRock
New York
|
-$17.1K |
MDCX Hedge Fund Activity: Q2 2026 in Review
23 of the 8,332 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma (MDCX) for Q2 2026, worth a combined $1.18M — down 82% from $6.48M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new MDCX positions and 7 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $118K. The largest seller was Private Advisor Group, exiting entirely with an estimated $110K sold.
- 23 institutional investors held Medicus Pharma (MDCX) as of Q2 2026, up from 21 in Q1 2026.
- Funds reported $1.18M of Medicus Pharma stock for Q2 2026, down 82% quarter-over-quarter.
- 9 funds opened new Medicus Pharma positions in Q2 2026 and 7 closed out, a net change of +2 holders.
- The largest Medicus Pharma buyer in Q2 2026 was Jane Street, an estimated $118K added.
- The largest Medicus Pharma seller in Q2 2026 was Private Advisor Group, an estimated $110K sold.
Based on aggregated 13F filings for Q2 2026.